The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2024

Filed:

Apr. 22, 2022
Applicant:

Caris Mpi, Inc., Irving, TX (US);

Inventors:

Jim Abraham, Gilbert, AZ (US);

David Spetzler, Paradise Valley, AZ (US);

Anthony Helmstetter, Gilbert, AZ (US);

Wolfgang Michael Korn, Mill Valley, CA (US);

Daniel Magee, Phoenix, AZ (US);

Assignee:

Caris MPI, Inc., Irving, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06N 20/20 (2019.01); G06N 20/00 (2019.01); G16B 20/10 (2019.01); G16B 40/00 (2019.01); G16H 20/40 (2018.01);
U.S. Cl.
CPC ...
G16H 20/40 (2018.01); G06N 20/00 (2019.01); G06N 20/20 (2019.01); G16B 20/10 (2019.02); G16B 40/00 (2019.02);
Abstract

Comprehensive molecular profiling provides a wealth of data concerning the molecular status of patient samples. Such data can be compared to patient response to treatments to identify biomarker signatures that predict response or non-response to such treatments. This approach has been applied to identify biomarker signatures that strongly correlate with response of colorectal cancer patients to FOLFOX. Described herein are data structures, data processing, and machine learning models to predict effectiveness of a treatment for a disease or disorder of a subject having a particular set of biomarkers, as well as an exemplary application of such a model to precision medicine, e.g., to methods for selecting a treatment based on a molecular profile, e.g., a treatment comprising administration of 5-fluorouracil/leucovorin combined with oxaliplatin (FOLFOX) or with irinotecan (FOLFIRI).


Find Patent Forward Citations

Loading…